Activation of the Met kinase confers acquired drug resistance in FGFR-targeted lung cancer therapy.

2016 
Activation of the Met kinase confers acquired drug resistance in FGFR-targeted lung cancer therapy
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    31
    References
    36
    Citations
    NaN
    KQI
    []